Diagnostyka
Diagnostyka SA is a leading Polish medical diagnostics and laboratory testing enterprise headquartered in Cracow, Poland. The company operates a massive nationwide network of clinical laboratories and blood collection points, providing routine pathology testing, molecular biology diagnostics, genetic screening, and specialized medical laboratory services to hospitals, healthcare clinics, and individual patients. Principal revenue is generated through medical diagnostic testing fees, laboratory analysis contracts, and healthcare service agreements. Diagnostyka SA maintains a prominent position within the Polish healthcare diagnostic sector.
6 of the funds FundTelligence covers report a position in Diagnostyka.
- Legal name
- Diagnostyka SA
- Sector
- Health Care
- Country
- Poland
- Funds holding it
- 6
Funds holding Diagnostyka
- Schroder ISF Emerging Markets Equity Impact — Schroders · 1.7 % (full portfolio disclosed, December 2025)
- Schroder ISF Emerging Europe — Schroders · 1.17 % (full portfolio disclosed, June 2026)
- Schroder ISF Global Emerging Markets Smaller Companies — Schroders · 1.06 % (full portfolio disclosed, June 2026)
- Swedbank Robur Emerging Europe — Swedbank · 0.6 % (full portfolio disclosed, October 2026)
- Schroder ISF Healthcare Innovation — Schroders · 0.29 % (full portfolio disclosed, June 2026)
- BlackRock iShares MSCI EM IMI Screened UCITS ETF — BlackRock · 0.0 % (full portfolio disclosed, October 2026)